Bronstein, Gewirtz & Grossman, LLC Encourages Light & Wonder, Inc. (LNW) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESSWIRE / October 14, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Light & Wonder, Inc. ("Light & Wonder" or "the Company") (NASDAQ:LNW). Investors who purchased Light & Wonder securities are encouraged to obtain additional information and assist the investigation by visiting […]

Beyond Adversity: How Avanza Capital Holdings Redefines Success and Celebrates an 8-Year Milestone

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Wall Street icons have long been revered for their groundbreaking philosophies and strategies. Behind their firms’ mystique often lies an intense culture of perfectionism, where even minor errors prompt detailed evaluations. In this high-stakes financial landscape, Avanza Capital Holdings stands apart as a non-traditional banking

Katten Recognized for DEI Efforts With Mansfield Certified Plus Designation

Katten announced today that the firm earned the Mansfield Rule Certified Plus designation for its efforts to ensure a broad slate of attorneys continues to be considered for leadership roles and that advancement opportunities across the firm are inclusive. https://mma.prnewswire.com/media/2530271/Katten_earned_the_Mansfield_Rule_Certified_Plus_designation.jpg “Katten is committed to expanding talent pools to diversify firm leadership and providing access to

Kodiak Sciences to Present at Innovate Retina 2024

Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today its participation in a presentation and panel at Innovate Retina 2024 on October 17, 2024, in Chicago, Illinois. Presentation and Panel details are below: — Presentation Title: Update on

CDK4/6 Inhibitors Market to Grow at Healthy Growth Rate by 2034 Owing to Expanded Usage of Approved Blockbuster CDK4/6 Inhibitors in Early-stage Breast Cancer and the Emergence of Newer Players in Other Indications | DelveInsight

The CDK4/6 inhibitors market is expected to grow significantly in the coming years. This is mainly due to the increasing incidence of HR+/HER2 breast cancer, the type for which CDK4/6 inhibitors are majorly prescribed.CDK4/6 inhibitors are now an established class, with all three approved CDK4/6 inhibitors reaching blockbuster status. An increasing number of emerging therapies

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Edwards between February 6, 2024 and July 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi

Groundfish Market projected to grow by USD 13.04 Billion from 2024-2028 driven by AI’s impact and increasing awareness of groundfish health benefits – Technavio

Report with market evolution powered by AI – The GlobalGroundfish Marketsize is estimated to grow by USD 13.04 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 5.92% during the forecast period. Growing awareness about health benefits of groundfishis driving market growth,with a trend towardsgrowth of sustainable fishing

ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of September 2024

DENVER, Oct. 14, 2024 (GLOBE NEWSWIRE) — ArrowMark Financial Corp., (NASDAQ: BANX) (“ArrowMark Financial”), today announced that BANX’s estimated and unaudited Net Asset Value (“NAV”) as of September 30, 2024, was $21.73. This estimated NAV is not a comprehensive statement of our financial condition or results for the month ended September 30, 2024. About ArrowMark

Global Aerospace Offers Valuable Insights on the Recent FAA Rulemaking Updates to Safety Management System Regulations

Morris Plains, NJ, Oct. 14, 2024 (GLOBE NEWSWIRE) — One of the cornerstones of safety in aviation is that it isn’t a state but rather a practice. How stakeholders manage safety on an ongoing basis is essential. Of course, maintaining a consistent focus on preventing injuries, property damage and other negative events isn’t easy. That

AILE Class Action Notice: Robbins LLP Reminds Investors of the Pending Lead Plaintiff Deadline in the Class Action Against iLearningEngines, Inc.

SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities who purchased or otherwise acquired iLearningEngines, Inc. (NASDAQ: AILE) securities between April 22, 2024 and August 28, 2024. iLearningEngines purports to be an “AI-powered learning automation” software company. For

Scroll to Top